Michael Perlis of the Perelman School of Medicine suggests that placebos, currently used mainly for control groups in clinical trials, may be worth another look for treatment and for chronic illnesses; they might be a key to increasing a drug’s lifetime effectiveness.

August 4, 2015 ・ From Philadelphia Inquirer